ID

29039

Descripción

A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Flexible Dose Study Evaluating the Efficacy, Safety and Tolerability of Extended-Release Bupropion Hydrochloride (150mg - 300mg once daily), Extended-Release Venlafaxine Hydrochloride (75mg - 150mg once daily) and Placebo in Subjects with Major Depressive Disorder

Palabras clave

  1. 21/2/18 21/2/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

21 de febrero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Study Evaluating Extended-Release Bupropion Hydrochloride and Extended-Release Venlafaxine Hydrochloride in Subjects with Major Depressive Disorder 101497

End of Study Record

  1. StudyEvent: ODM
    1. End of Study Record
Study Conclusion
Descripción

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008976
Did the subject discontinue the study prematurely?
Descripción

NOTE : The subject is considered to have discontinued if they did not complete the 8 weeks of treatment, the Taper Visit (if necessary), the Mandatory Safety Follow-Up Visit, the Additional Safety Follow-Up Visit (if required) and the home pregnancy test (if required). If 'Yes' please mark the primary reason for discontinuation.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C4018905
Reason
Descripción

reason for premature discontinuation

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C0008976
Date of subject completion or discontinuation from the study
Descripción

date of study completion or discontinuation

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2348577
UMLS CUI [1,2]
C0011008
Status of Treatment Blind
Descripción

Status of Treatment Blind

Alias
UMLS CUI-1
C0749659
UMLS CUI-2
C2347038
Was the treatment blind for this subject broken during the study?
Descripción

If 'Yes' please complete the following.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3897431
Date
Descripción

date of broken treatment blind

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C0011008
Reason
Descripción

(Medical emergency requiring identity of investigational product for further treatment)

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C0392360
Investigational Product Discontinuation
Descripción

Investigational Product Discontinuation

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0457454
Was the investigational product stopped permanently before the end of the scheduled treatment period?
Descripción

If Yes, select the primary reason the investigational product was stopped.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0457454
Select the primary reason the investigational product was stopped.
Descripción

reason for investigational product discontinuation

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C0457454
Comments
Descripción

Comments

Alias
UMLS CUI-1
C0947611
Comments
Descripción

Research Comments

Tipo de datos

text

Alias
UMLS CUI [1]
C0947611

Similar models

End of Study Record

  1. StudyEvent: ODM
    1. End of Study Record
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008976 (UMLS CUI-2)
premature discontination
Item
Did the subject discontinue the study prematurely?
boolean
C2348568 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C4018905 (UMLS CUI [1,3])
reason for premature discontinuation
Item
Reason
text
C0392360 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
date of study completion or discontinuation
Item
Date of subject completion or discontinuation from the study
date
C2348577 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Status of Treatment Blind
C0749659 (UMLS CUI-1)
C2347038 (UMLS CUI-2)
treatment blind broken
Item
Was the treatment blind for this subject broken during the study?
boolean
C3897431 (UMLS CUI [1])
date of broken treatment blind
Item
Date
boolean
C3897431 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
reason of broken treatment blind
Item
Reason
text
C3897431 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Item Group
Investigational Product Discontinuation
C0304229 (UMLS CUI-1)
C0457454 (UMLS CUI-2)
Investigational Product Discontinuation
Item
Was the investigational product stopped permanently before the end of the scheduled treatment period?
boolean
C0304229 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
reason for investigational product discontinuation
Item
Select the primary reason the investigational product was stopped.
text
C0392360 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
Item Group
Comments
C0947611 (UMLS CUI-1)
Research Comments
Item
Comments
text
C0947611 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial